Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naive locally advanced upper aerodigestive malignancy

  • Corey J. Langer
  • , Karen Duffy
  • , Eric M. Horwitz
  • , Samuel Litwin
  • , Elizabeth Rosvold
  • , Jessie Schol
  • , Eileen Keenan
  • , Nicos Nicolaou
  • , Craig D. Friedman
  • , John A. Ridge

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naive locally advanced upper aerodigestive malignancy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science